pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Bayer, the most common co-covered peer. The tracked stories average 2 original sources each. Monsanto appears in 1 tracked Biotech story from February 18, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Monsanto
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Bayer, the most common co-covered peer. The tracked stories average 2 original sources each. Monsanto appears in 1 tracked Biotech story from February 18, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Monsanto. Shared-story counts are live from our verified record — not editorial picks.
Bayer has reached a $7.25 billion settlement agreement to resolve long-standing litigation surrounding its Roundup herbicide. The deal includes a 21-year framework designed to provide legal and financial certainty for the company following years of costly courtroom battles.